Apparatus and methods for optical coherence tomography and two-photon luminescence imaging

US10495440B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10495440-B2
Application numberUS-201615264505-A
CountryUS
Kind codeB2
Filing dateSep 13, 2016
Priority dateMar 14, 2013
Publication dateDec 3, 2019
Grant dateDec 3, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Exemplary embodiments of the present disclosure include a combined catheter-based optical coherence tomography-two-photon luminescence (OCT-TPL) imaging system. Exemplary embodiments further include methods to detect, and further characterize the distribution of cellular components (e.g., macrophage, collagen/elastin fiber, lipid droplet) in thin-cap fibroatheromas with high spatial resolution in vivo.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of imaging a sample site, the method comprising: emitting a first wavelength from an optical coherence tomography light source toward a sample site; emitting a second wavelength from a short-pulsed light source toward the sample site, wherein the first wavelength from the optical coherence tomography light source and the second wavelength from the short-pulsed light source are simultaneously transmitted through a double-clad photonic crystal fiber, wherein: the double-clad photonic crystal fiber comprises a single-mode core embedded in a multimode fiber structure; the single-mode core has a lower numerical aperture (NA) than the multimode fiber structure; detecting an optical coherence tomography signal from the sample site, wherein the optical coherence tomography signal is generated from the first wavelength; and detecting a two-photon luminescence emission signal from the sample site, wherein: the two-photon luminescence emission signal is induced by the second wavelength; the two-photon luminescence emission signal is transmitted at the same time as the first wavelength and the second wavelength; the two-photon luminescence emission signal is transmitted in an opposite direction from the first wavelength and the second wavelength; the optical coherence tomography signal comprises radial and azimuthal dimensional data; and the two-photon luminescence signal comprises an azimuthal signal; and adding a radial dimension to the two-photon luminescence data, wherein: adding the radial dimension to the two-photon luminescence data comprises using a radial probability distribution function that is normalized by the two-photon luminescence azimuthal signal; and the radial probability distribution function is determined using: optical properties of the imaging system; the distance between the catheter-based imaging system and a lumenal wall into which the catheter-based imaging system is inserted; and the optical properties of tissue of the lumenal wall; and generating three-dimensional images based on data obtained from the catheter-based imaging system as the catheter-based imaging system is moved axially along a lumen. 2. The method of claim 1 wherein the optical coherence tomography signal and the two-photon luminescence signal are detected from a plurality sample sites. 3. The method of claim 1 wherein the sample comprises a tissue. 4. The method of claim 3 wherein the tissue is epithelial tissue. 5. The method of claim 3 where the tissue is arterial tissue. 6. The method of claim 5 where the arterial tissue is located in a coronary artery. 7. The method of claim 3 wherein the tissue is a vascular luminal surface. 8. The method of claim 3 wherein the tissue is oral mucosa. 9. The method of claim 1 wherein the optical coherence tomography signal is used to generate an optical coherence tomography tomogram. 10. The method of claim 1 wherein the two-photon luminescence signal is co-registered with an optical coherence tomography tomogram. 11. The method of claim 1 further comprising displaying two-dimensional two-photon luminescence data on a three-dimensional optical coherence tomography tomogram. 12. The method of claim 1 wherein a first processing element uses the optical coherence tomography signal and constructs an optical coherence tomography tomogram. 13. The method of claim 12 wherein the first processing element is a central processing unit or a graphics processing unit. 14. The method of claim 12 wherein a second processing element renders for viewing a co-registered two-photon luminescence image on an optical coherence tomography tomogram. 15. The method of claim 1 wherein the sample site comprises a nanoparticle. 16. The method of claim 15 wherein the two-photon luminescence signal is emitted from the nanoparticle. 17. The method of claim 1 wherein the two-photon luminescence emission signal is emitted from tissue of the sample site. 18. A method for displaying imaging data, the method comprising: obtaining optical coherence tomography data with an imaging system; obtaining two-photon luminescence data from a plurality of luminescing particles with the imaging system, wherein: the imaging system is a catheter-based imaging system; the optical coherence tomography data is generated from light emitted at a first wavelength from an optical coherence tomography light source; the optical coherence tomography data comprises radial and azimuthal dimensional data; the two-photon luminescence data comprises an azimuthal signal; the two-photon luminescence data is generated from light emitted at a second wavelength from a short-pulsed light source; and the first wavelength from the optical coherence tomography light source and the second wavelength from the short-pulsed light source are simultaneously transmitted through a double-clad photonic crystal fiber, wherein: the double-clad photonic crystal fiber comprises a single-mode core embedded in a multimode fiber structure; the single-mode core has a lower numerical aperture (NA) than the multimode fiber structure; the two-photon luminescence emission data is transmitted at the same time as the first wavelength and the second wavelength; and the two-photon luminescence emission data is transmitted in an opposite direction from the first wavelength and the second wavelength; and adding a radial dimension to the two-photon luminescence data, wherein: adding the radial dimension to the two-photon luminescence data comprises using a radial probability distribution function that is normalized by the two-photon luminescence azimuthal signal; and the radial probability distribution function is determined using: optical properties of the imaging system: the distance between the catheter-based imaging system and a lumenal wall into which the catheter-based imaging system is inserted; and the optical properties of tissue of the lumenal wall; simultaneously displaying the optical coherence tomography data and the two-photon luminescence data in a combined image; and generating three-dimensional images based on data obtained from the catheter-based imaging system as the catheter-based imaging system is moved axially along a lumen. 19. The method of claim 18 wherein the luminescing particle is a nanoparticle. 20. The method of claim 18 further comprising generating three-dimensional images based on data obtained from the catheter-based imaging system as the catheter-based imaging system is moved axially along a lumen. 21. The method of claim 18 , wherein the radial probability distribution function is determined using assuming a uniform distribution of nanoparticles.

Assignees

Inventors

Classifications

  • Luminescence · CPC title

  • G01B9/0203Primary

    With imaging systems · CPC title

  • Two or more frequencies or sources used for interferometric measurement (using only beat G01B9/02003) · CPC title

  • Arrangements in relation to a camera or imaging device (processing or control of video signals generated by an endoscope H04N23/60, H04N23/70) · CPC title

  • adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10495440B2 cover?
Exemplary embodiments of the present disclosure include a combined catheter-based optical coherence tomography-two-photon luminescence (OCT-TPL) imaging system. Exemplary embodiments further include methods to detect, and further characterize the distribution of cellular components (e.g., macrophage, collagen/elastin fiber, lipid droplet) in thin-cap fibroatheromas with high spatial resolution …
Who is the assignee on this patent?
Res Found Dev
What technology area does this patent fall under?
Primary CPC classification G01B9/0203. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).